Results 191 to 200 of about 17,612,218 (346)

Coronary atherectomy in acute ischemic syndromes: Implications of thrombus on treatment outcome

, 1991
Barry Kramer, Timothy J. Larkin, Paulette Niemyski, Michele Parker   +3 more
openalex   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Endoscopic treatment outcome of oesophageal gastrointestinal stromal tumours. [PDF]

World J Gastroenterol
Xu EP, Qi ZP, Zhang JW, Li B, Ren Z, Cai MY, Cai SL, Lv ZT, Chen ZH, Liu JY, Zhong YS, Zhou PH, Shi Q.   +12 more
europepmc   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Contact Sensitization to Methylchloroisothiazolinone/Methylisothiazolinone is Associated With Poor Treatment Outcome: A Retrospective Study. [PDF]

Ann Dermatol
Jeon JJ, Kim YH, Jung SW, Lee S, Choi EH.   +4 more
europepmc   +1 more source

Demographic, Clinical, and Treatment Parameters Influencing the Outcome of Acute Cystitis [PDF]

, 1999
Roger Echols, Robert Tosiello, Daniel Haverstock, Alan D. Tice   +3 more
openalex   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

Drug Survival and Predictors of Systemic Treatment Outcome in Atopic Dermatitis: Data From a Nationwide Swedish Cohort. [PDF]

Acta Derm Venereol
Jonsson PO, Tayefi M, Svedbom A, Bradley M, Johansson EK.   +4 more
europepmc   +1 more source

The influence of HLA‐matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA [PDF]

, 1998
S. Keating, Théo de Witte, Stefan Suciu, Roel Willemze, Marcel Hayat, Boris Labar, L Resegotti, Pierluigi Rossi Ferrini, Francesco Paolo Caronia, M Dardenne, G. Solbu, M. C. Petti, M. L. Vegna, F Mandelli, R Zittoun   +14 more
openalex   +1 more source

Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.

Journal of Clinical Investigation, 2014
Eric G. Meissner, David Wu, A. Osinusi, Dimitra Bon, K. Virtaneva, D. Sturdevant, S. Porcella, Honghui Wang, E. Herrmann, J. Mchutchison, A. Suffredini, M. Polis, S. Hewitt, L. Prokunina-Olsson, H. Masur, A. Fauci, S. Kottilil   +16 more
semanticscholar   +1 more source